Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional

Long-term Extension of Phase 3 Study of ALZ- 801 in APOE4/4 Early AD Subjects

ClinicalTrials.gov ID: NCT06304883

Public ClinicalTrials.gov record NCT06304883. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 9:36 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Long-term Extension of a Phase 3, Multicenter, Randomized, Double-Blind, Placebo- Controlled Study of the Efficacy, Safety, and Biomarker Effects of ALZ-801 in Subjects With Early Alzheimer's Disease and APOE4/4 Genotype

Study identification

NCT ID
NCT06304883
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Alzheon Inc.
Industry
Enrollment
163 participants

Conditions and interventions

Interventions

  • Experimental: ALZ-801 Drug

Drug

Eligibility (public fields only)

Age range
50 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 1, 2024
Primary completion
Mar 10, 2026
Completion
Mar 10, 2026
Last update posted
Jun 24, 2026

2024 – 2026

United States locations

U.S. sites
29
U.S. states
15
U.S. cities
29
Facility City State ZIP Site status
Xenoscience, Inc. Phoenix Arizona 85004
Banner Sun Health Research Institute Sun City Arizona 85351
ATP Clinical Research Costa Mesa California 92626
Torrance Clinical Research Institute Lomita California 90717
Sutter Health Sacramento California 95816
JEM Research Institute, Headlands Site Atlantis Florida 33462
K2 Medical Research, LLC Maitland Florida 32751
Mount Sinai Medical Center Miami Beach Florida 33140
Aqualane Clinical Research Naples Florida 34105
Charter Research Orlando Florida 32803
Progressive Medical Research Port Orange Florida 32127
ALZ Research and Treatment Center (A.R.T.C.) Stuart Florida 34997
ALZ Research and Treatment Center (A.R.T.C.) Wellington Florida 33414
Premiere Research Institute West Palm Beach Florida 33407
Columbus Memory Center Columbus Georgia 31909
Fort Wayne Neurological Center Fort Wayne Indiana 46804
Headlands Research Eastern MA Plymouth Massachusetts 02360
Advanced Memory Research Center Toms River New Jersey 08755
Neurological Associates of Albany Albany New York 12208
NYU Alzheimer's Disease Research Center New York New York 10016
University of Rochester Medical Center Rochester New York 14620
Triad Clinical Trials Greensboro North Carolina 27410
AMC Research Matthews North Carolina 28105
Center for Cognitive Health Portland Oregon 97225
Abington Neurological Associates Abington Pennsylvania 19001
Rhode Island Mood & Memory Research Institute East Providence Rhode Island 02914
UT Health Science Center at Houston Houston Texas 77054
Re:Cognition Health Fairfax Virginia 22031
Northwest Clinical Research Center Bellevue Washington 98007

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 12 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06304883, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 24, 2026 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06304883 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →